Danielle Craig
Payments from drug & device makers
Across 182 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Sumitomo Pharma America, Inc.$272
- AbbVie$214
- Boehringer Ingelheim$207
- Daiichi Sankyo Inc.$195
- Novo Nordisk$193
- plus $2K from 32 others
What the payments were for
- Travel & lodging$66416%
- Food & beverage$3,40284%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 30 | $1,383 |
| Sumitomo Pharma America, Inc. | 12 | $272 |
| AbbVie | 13 | $214 |
| Boehringer Ingelheim | 13 | $207 |
| Daiichi Sankyo Inc. | 9 | $195 |
| Novo Nordisk | 12 | $193 |
| AstraZeneca | 14 | $190 |
| Pfizer | 11 | $188 |
| Bayer | 9 | $159 |
| Merck | 10 | $145 |
| Esperion Therapeutics, Inc. | 5 | $106 |
| Procept Biorobotics Corporation | 1 | $99 |
| Dexcom, Inc. | 5 | $75 |
| Johnson & Johnson | 4 | $62 |
| Mylan Specialty L.p. | 4 | $58 |
| Photocure Inc | 2 | $52 |
| Laborie Medical Technologies Corp. | 3 | $52 |
| Amgen | 3 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Tolmar, Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Urogen Pharma, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,066 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 179 | $134,554 |
| MyrbetriqMirabegron | 149 | $79,377 |
| Solifenacin Succinate | 84 | $6,968 |
| Tamsulosin Hcl | 330 | $4,729 |
| Trimethoprim | 56 | $2,988 |
| Estradiol | 30 | $2,105 |
| Oxybutynin Chloride ErOxybutynin Chloride | 92 | $1,719 |
| Finasteride | 92 | $996 |
| Cephalexin | 142 | $928 |
| Oxybutynin Chloride | 54 | $776 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $710 |
| NitrofurantoinNitrofurantoin Macrocrystal | 25 | $560 |
| Testosterone Cypionate | 15 | $509 |
| Cefdinir | 40 | $454 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $407 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $272 | $134,554179 claims |
| Astellas Pharma US IncMyrbetriq | $30 | $79,377149 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.
Other family in Paris
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
- Brandy BiedermanHixson$448K
- Cynthia MillerMurfreesboro$384K
- Tamera ThoenerNashville$254K
- April SwonerHermitage$246K
- Jennifer WilliamsNashville$213K
- Chantil JeffreysGermantown$195K
- Laura PorchCordova$148K
- Lori LankfordNashville$148K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.